Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Oct 14;7(10):87.
doi: 10.3390/genes7100087.

Molecular Correlates and Recent Advancements in the Diagnosis and Screening of FMR1-Related Disorders

Affiliations
Review

Molecular Correlates and Recent Advancements in the Diagnosis and Screening of FMR1-Related Disorders

Indhu-Shree Rajan-Babu et al. Genes (Basel). .

Abstract

Fragile X syndrome (FXS) is the most common monogenic cause of intellectual disability and autism. Molecular diagnostic testing of FXS and related disorders (fragile X-associated primary ovarian insufficiency (FXPOI) and fragile X-associated tremor/ataxia syndrome (FXTAS)) relies on a combination of polymerase chain reaction (PCR) and Southern blot (SB) for the fragile X mental retardation 1 (FMR1) CGG-repeat expansion and methylation analyses. Recent advancements in PCR-based technologies have enabled the characterization of the complete spectrum of CGG-repeat mutation, with or without methylation assessment, and, as a result, have reduced our reliance on the labor- and time-intensive SB, which is the gold standard FXS diagnostic test. The newer and more robust triplet-primed PCR or TP-PCR assays allow the mapping of AGG interruptions and enable the predictive analysis of the risks of unstable CGG expansion during mother-to-child transmission. In this review, we have summarized the correlation between several molecular elements, including CGG-repeat size, methylation, mosaicism and skewed X-chromosome inactivation, and the extent of clinical involvement in patients with FMR1-related disorders, and reviewed key developments in PCR-based methodologies for the molecular diagnosis of FXS, FXTAS and FXPOI, and large-scale (CGG)n expansion screening in newborns, women of reproductive age and high-risk populations.

Keywords: AGG interruption; CGG repeat; FMR1; FXPOI; FXTAS; fragile X syndrome; melting curve analysis; methylation; screening; triplet-primed PCR.

PubMed Disclaimer

Conflict of interest statement

Samuel S. Chong is an inventor of the dTP-PCR and msTP-PCR CE and MCA assays. Indhu-Shree Rajan-Babu declares no conflict of interest.

Figures

Figure 1
Figure 1
Flanking or repeat-spanning PCR: (A) Schematic depicting the flanking PCR primer design; and (B) expected capillary electrophoresis profiles of normal, premutation and full-mutation males and females.
Figure 2
Figure 2
Triplet-Primed PCR or TP-PCR: (A) Schematic depicting the TP-PCR primer design; and (B) expected capillary electrophoresis profiles of normal, premutation and full-mutation males and females. For simplification, the Tail primer is not shown.
Figure 3
Figure 3
Melting curve analysis (MCA) of TP-PCR amplicons. Schematic illustrating how MCA of heterogeneous TP-PCR amplicons results in the generation of a single melt peak. Dissociation of double-stranded PCR products and re-distribution of SYBR Green I Dye from the shorter to larger fragments with gradually increasing temperature (Temp A to Temp C) is shown. At Temp D, when the largest amplicon strands dissociate, SYBR Green I is completely released and remains unbound to DNA, resulting in a sharp decrease in fluorescence. −dF/dT, first negative derivative of fluorescence versus temperature.

Similar articles

Cited by

References

    1. Saul R.A., Tarleton J.C. FMR1-Related Disorders. In: Pagon R.A., Adam M.P., Ardinger H.H., Wallace S.E., Amemiya A., Bean L.J.H., Bird T.D., Fong C.T., Mefford H.C., Smith R.J.H., et al., editors. GeneReviews(R) University of Washington; Seattle, WA, USA: 1993.
    1. Usdin K., Hayward B.E., Kumari D., Lokanga R.A., Sciascia N., Zhao X.N. Repeat-mediated genetic and epigenetic changes at the FMR1 locus in the Fragile X-related disorders. Front. Genet. 2014 doi: 10.3389/fgene.2014.00226. - DOI - PMC - PubMed
    1. Fernandez E., Rajan N., Bagni C. The FMRP regulon: From targets to disease convergence. Front. Neurosci. 2013 doi: 10.3389/fnins.2013.00191. - DOI - PMC - PubMed
    1. Coffee B., Ikeda M., Budimirovic D.B., Hjelm L.N., Kaufmann W.E., Warren S.T. Mosaic FMR1 deletion causes fragile X syndrome and can lead to molecular misdiagnosis: A case report and review of the literature. Am. J. Med. Genet. A. 2008;146A:1358–1367. doi: 10.1002/ajmg.a.32261. - DOI - PMC - PubMed
    1. De Boulle K., Verkerk A.J., Reyniers E., Vits L., Hendrickx J., Van Roy B., Van den Bos F., de Graaff E., Oostra B.A., Willems P.J. A point mutation in the FMR-1 gene associated with fragile X mental retardation. Nat. Genet. 1993;3:31–35. doi: 10.1038/ng0193-31. - DOI - PubMed